Zhejiang Huakang Pharmaceutical Co., Ltd.SSE: 605077

Announcement on Addition of Implementing Entities for Projects Funded by the Convertible Corporate Bond Issued to Non-specific Objects

· Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

Zhejiang Huakang Pharmaceutical Co., Ltd. announced the addition of implementing entities for its convertible corporate bond-funded projects. The new entity, Zhejiang Jinggong Food Technology Co., Ltd., will join the existing project team without changing the use of raised funds. This adjustment aims to enhance operational efficiency and financial management within the company's corn processing project. The board confirmed that this change does not require shareholder approval as it does not alter the project's funding purposes.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Addition of Implementing Entities for Projects Funded by the Convertible Corporate Bond Issued to Non-specific Objects

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huakang Pharmaceutical

Later from Zhejiang Huakang Pharmaceutical

All Zhejiang Huakang Pharmaceutical news releases